Lineage Cell Therapeutics
LCTX
#8976
Rank
A$0.16 B
Marketcap
$0.72
Share price
3.62%
Change (1 day)
-67.28%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2023 (TTM): -$0.20

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.22. In 2022 the company made an earnings per share (EPS) of -$0.25 an increase over its 2021 EPS that were of -$0.43.

EPS history for Lineage Cell Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.20-21.21%
2022-$0.25-42.31%
2021-$0.4385.71%
2020-$0.23250%
2019-$0.06616-88.57%
2018-$0.58105.88%
2017-$0.28-153.13%
2016$0.53-154.24%
2015-$0.985.36%
2014-$0.93-30.86%
2013-$1.3488.37%
2012-$0.7119.44%
2011-$0.6033.33%
2010-$0.4568.75%
2009-$0.26-5.88%
2008-$0.28183.33%
2007-$0.09924-25%
2006-$0.13-27.27%
2005-$0.18-38.89%
2004-$0.3038.46%
2003-$0.22-43.48%
2002-$0.38-26.63%
2001-$0.52-28.75%
2000-$0.73-13.73%
1999-$0.84
1997-$0.553.13%
1996-$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.61 1,576.92%๐Ÿ‡บ๐Ÿ‡ธ USA